Joel Greenblatt - Gotham Asset Management
Holding/activity history for Akebia Therapeutics, Inc. (AKBA)
← All AKBA superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 27,172 | <0.01 | Add 70.14% | $1.14–1.63 · VW $1.39i | $37,769 | SEC | |
| 2025 Q4 | 15,970 | <0.01 | Add 10.15% | $1.45–3.20 · VW $1.99i | $25,712 | SEC | |
| 2025 Q3 | 14,499 | <0.01 | Reduce 6.87% | $2.66–4.08 · VW $3.29i | $39,582 | SEC | |
| 2025 Q2 | 15,569 | <0.01 | Buy | <0.01 | $1.52–4.08 · VW $2.93i | $56,671 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | $2.35–3.91 · VW $2.87i | SEC | |
| 2021 Q2 | 19,195 | <0.01 | Buy | <0.01 | $2.74–4.33 · VW $3.46i | $73,000 | SEC |
Price snapshot:
Current price$1.38
Avg. buy price$2.60
+/- since buy-46.97%
52-week low$0.82
52-week high$4.04